These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 1905509)

  • 1. Synergistic effect of growth hormone and gonadotropins in achieving conception in "clonidine-negative" patients with unexplained infertility.
    Blumenfeld Z; Amit T; Barkey RJ; Lunenfeld B; Brandes JM
    Ann N Y Acad Sci; 1991; 626():250-65. PubMed ID: 1905509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of growth hormone in ovulation induction.
    Blumenfeld Z; Amit T
    Ann Med; 1994 Aug; 26(4):249-54. PubMed ID: 7946243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of growth hormone (GH), GH-receptor and GH-binding protein in reproduction and ovulation induction.
    Blumenfeld Z; Amit T
    J Pediatr Endocrinol Metab; 1996; 9(2):145-62. PubMed ID: 8887137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone (GH)-binding protein regulation by estrogen, progesterone, and gonadotropins in human: the effect of ovulation induction with menopausal gonadotropins, GH, and gestation.
    Blumenfeld Z; Barkey RJ; Youdim MB; Brandes JM; Amit T
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1242-9. PubMed ID: 1430084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study.
    Younis JS; Simon A; Koren R; Dorembus D; Schenker JG; Laufer N
    Fertil Steril; 1992 Sep; 58(3):575-80. PubMed ID: 1387849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potentiating effect of growth hormone on follicle stimulation with human menopausal gonadotropin in a panhypopituitary patient.
    Blumenfeld Z; Lunenfeld B
    Fertil Steril; 1989 Aug; 52(2):328-31. PubMed ID: 2502442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone co-treatment for ovulation induction may enhance conception in the co-treatment and succeeding cycles, in clonidine negative but not clonidine positive patients.
    Blumenfeld Z; Dirnfeld M; Gonen Y; Abramovici H
    Hum Reprod; 1994 Feb; 9(2):209-13. PubMed ID: 8027274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant growth hormone for induction of ovulation with gonadotrophin-releasing hormone agonist and gonadotrophins in polycystic ovary syndrome: a randomized, double-blind, placebo controlled trial.
    Homburg R; Levy T; Ben-Rafael Z
    Hum Reprod; 1995 Oct; 10(10):2550-3. PubMed ID: 8567768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supplementary growth hormone treatment of women with poor ovarian response to exogenous gonadotrophins: changes in serum and follicular fluid insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3).
    Huang ZH; Baxter RC; Hughes SM; Matson PL; Lieberman BA; Morris ID
    Hum Reprod; 1993 Jun; 8(6):850-7. PubMed ID: 7688379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and endocrinological changes in women following ovulation induction using buserelin acetate/human menopausal gonadotrophin augmented with biosynthetic human growth hormone.
    Hughes SM; Huang ZH; Matson PL; Buck P; Lieberman BA; Morris ID
    Hum Reprod; 1992 Jul; 7(6):770-5. PubMed ID: 1500473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone co-treatment in IVF/ICSI cycles in poor responders.
    Ob'edkova K; Kogan I; Krikheli I; Dzhemlikhanova L; Muller V; Mekina I; Lesik E; Komarova E; Mazilina M; Niauri D; Gzgzyan A; Aylamazyan E
    Gynecol Endocrinol; 2017; 33(sup1):15-17. PubMed ID: 29264990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization.
    Bergh C; Carlström K; Selleskog U; Hillensjö T
    Eur J Endocrinol; 1996 Feb; 134(2):190-6. PubMed ID: 8630518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of controlled ovarian hyperstimulation on oocyte quality in terms of the incidence of apoptotic granulosa cells.
    Kaneko T; Saito H; Takahashi T; Ohta N; Saito T; Hiroi M
    J Assist Reprod Genet; 2000 Nov; 17(10):580-5. PubMed ID: 11209539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of growth hormone responses to growth hormone-releasing factor and clonidine in women with normal or poor ovarian response to gonadotropin stimulation.
    Salat-Baroux J; Rotten D; Alvarez S; Antoine JM
    Fertil Steril; 1993 Nov; 60(5):791-9. PubMed ID: 8224263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Luteal phase hyperprolactinemia during ovulation induction with human menopausal gonadotropins: incidence, recurrence, and effect on pregnancy rates.
    Tippet PD; Simon JA; Rifka SM; Falk RJ
    Obstet Gynecol; 1989 Apr; 73(4):613-6. PubMed ID: 2494621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteinizing response to human chorionic gonadotropin does not predict outcome in gonadotropin releasing hormone agonist-suppressed/human menopausal gonadotropin-stimulated in vitro fertilization (IVF) cycles.
    Penzias AS; Shamma FN; Gutmann JN; Seifer DB; DeCherney AH; Lavy G
    J Assist Reprod Genet; 1992 Jun; 9(3):244-7. PubMed ID: 1525454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delaying human chorionic gonadotropin administration in human menopausal gonadotropin-induced cycles decreases successful in vitro fertilization of human oocytes.
    Laufer N; DeCherney AH; Tarlatzis BC; Zuckerman AL; Polan ML; Dlugi AM; Graebe R; Barnea ER; Naftolin F
    Fertil Steril; 1984 Aug; 42(2):198-203. PubMed ID: 6430722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma hormones in human gonadotropin induced ovulation.
    Wu CH
    Obstet Gynecol; 1977 Mar; 49(3):308-13. PubMed ID: 840459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.